منابع مشابه
To scan or not to scan: DaT is the question.
Neurology 2012;78:688–689 The Food and Drug Administration (FDA) recently approved [I]ioflupane ([I]-fluoropropyl CIT), a dopamine transporter (DAT) radioligand, for SPECT to “assist in the evaluation of adult patients with suspected parkinsonian syndromes (PS).”1 This permits physicians to prescribe [I]ioflupane SPECT scans as part of clinical practice. Advertisements encourage clinicians to o...
متن کاملTo scan or not to scan, to enhance or not to enhance? That is the question.
Hong Kong Med J ⎥ Volume 20 Number 5 ⎥ October 2014 ⎥ www.hkmj.org A 12-year-old boy presented to the Emergency Department (ED) with reduced level of consciousness in February 2011. Collateral history established a prehospital witnessed seizure (requiring benzodiazepine administration) preceded by auditory hallucinations. Apart from uncomplicated malaria at the age of 5 years, there was no othe...
متن کاملSCAN heads to kindergarten.
It is hard to believe, but SCAN turns five in 2011 and things are going well. We received our first impact factor of 4.203, which places us #9 on the list of psychology journals and in the top 25% of all neuroscience journals. We have also become the official journal of the Social and Affective Neuroscience Society that hosts the SAN meeting each year. And we are growing. We have been running f...
متن کاملDesign for Testability I: from Full Scan to Partial Scan
As can be seen in Figure 6.1, there is a stage called test development where it basically consists of three activities; test generation, fault simulation and design for testability implementation. Test generation is a method of generating an input sequence that can distinguish between good chip and defective chip when the input sequence (test sequence) is applied to the chip using a tester. Fau...
متن کاملTo scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy.
Doctor Belhocine and his group have conducted a seminal Phase I study correlating Tc-rh-annexin V imaging with clinical outcome in patients with late-stage lung cancer and lymphoma within 1–3 days after chemotherapy (1). The conclusions that can be drawn from this study are quite important and include: (a) annexin V imaging can be performed serially and safely; (b) significant posttreatment inc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2013
ISSN: 1537-6591,1058-4838
DOI: 10.1093/cid/cis991